David Schubert

Bio

Mr Schubert is President and Chief Business Officer of Accelerator Corporation. Prior to joining Accelerator in 2005, Mr Schubert was the Founder and President of CellExSys Inc, a biotechnology company focused on the creation of personalized medicines for the treatment of cancer and infectious diseases. In 1997, Mr Schubert joined Targeted Genetics Corporation as Director, Communications and Strategic Relations and was promoted to Senior Director in 1999. He oversaw all investor relations and corporate communications activities and participated in a variety of business development initiatives. In April of 2000, he was appointed to the position of Senior Director, Strategic Initiatives, a position in which he focused on spinning out the company's assets in the cellular therapy area and the subsequent creation of CellExSys Inc in November of 2000. Previously, Mr Schubert was a Biotechnology Research Associate at Vector Securities International (acquired by Prudential Securities). From 1994 to 1996 he was the Senior Market Manager for the Immunotherapy Division of Baxter Healthcare Corporation, where he developed and implemented strategic marketing programs for a multi-million dollar portfolio of products for utilization in the bone marrow transplantation and cellular therapies markets. From 1993 to 1994 he was the Assistant to the President of Baxter International's Biotech Europe Group located in Munich, Germany. Mr Schubert is a member of the Board of Directors of Accentia Biopharmaceuticals Inc (NASDAQ: ABPI). Mr Schubert holds an MBA degree with concentrations in Marketing and Management from The Pennsylvania State University, an MS in Biology with a concentration in Immunology from Utah State University and a BS in Biology and a BA in Psychology from Eastern Nazarene College in Quincy, Massachusetts.